Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
9.12
-0.03 (-0.27%)
At close: Jul 18, 2025, 4:00 PM
9.11
-0.01 (-0.05%)
After-hours: Jul 18, 2025, 4:42 PM EDT

Sage Therapeutics Stock Forecast

Stock Price Forecast

The 18 analysts that cover Sage Therapeutics stock have a consensus rating of "Hold" and an average price target of $9.89, which forecasts a 8.5% increase in the stock price over the next year. The lowest target is $4 and the highest is $26.

Price Target: $9.89 (+8.5%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$4.00$9.89$9.00$26
Change-56.12%+8.50%-1.26%+185.24%

Analyst Ratings

The average analyst rating for Sage Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy000000
Buy333321
Hold151514141516
Sell111111
Strong Sell111100
Total202019191818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Scotiabank
Scotiabank
Hold
Downgrades
$12$9.2
HoldDowngrades$12$9.2+0.93%Jul 8, 2025
Baird
Baird
Hold
Maintains
$7$9
HoldMaintains$7$9-1.26%Jun 20, 2025
Piper Sandler
Piper Sandler
Hold
Downgrades
$9$8.5
HoldDowngrades$9$8.5-6.75%Jun 17, 2025
Truist Securities
Truist Securities
Hold
Maintains
$8$9
HoldMaintains$8$9-1.26%Jun 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$12
HoldReiterates$12+31.65%Jun 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
83.19M
from 41.24M
Increased by 101.71%
Revenue Next Year
118.38M
from 83.19M
Increased by 42.30%
EPS This Year
-3.67
from -6.59
EPS Next Year
-2.94
from -3.67
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
1.11B6.31M7.69M86.46M41.24M83.19M118.38M155.38M
Revenue Growth
16,123.06%-99.43%21.85%1,024.84%-52.30%101.71%42.30%31.26%
EPS
11.43-7.80-8.98-9.05-6.59-3.67-2.94-2.00
EPS Growth
--------
Forward PE
--------
No. Analysts
-----202015
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High136.4M198.7M229.8M
Avg83.2M118.4M155.4M
Low61.7M78.4M110.5M

Revenue Growth

Revenue Growth20252026202720282029
High
230.7%
138.8%
94.1%
Avg
101.7%
42.3%
31.3%
Low
49.6%
-5.8%
-6.7%

EPS Forecast

EPS20252026202720282029
High-3.08-1.76-0.74
Avg-3.67-2.94-2.00
Low-3.90-3.85-3.90

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.